Danone quiet on medical nutrition business IPO reports
Danone has declined to comment on reports it is considering an initial public offering (IPO) of shares in its medical nutrition business.
Danone has declined to comment on reports it is considering an initial public offering (IPO) of shares in its medical nutrition business.
Lactose intolerant individuals have a decreased risk of developing lung, breast and ovarian cancers, fresh Swedish findings suggest.